Bruker Corporation (BRKR)

NASDAQ: BRKR · IEX Real-Time Price · USD
+0.68 (1.12%)
Aug 17, 2022 4:00 PM EDT - Market closed
Market Cap 9.10B
Revenue (ttm) 2.48B
Net Income (ttm) 273.90M
Shares Out 148.14M
EPS (ttm) 1.80
PE Ratio 34.13
Forward PE 37.04
Dividend $0.18 (0.29%)
Ex-Dividend Date Aug 31, 2022
Volume 897,027
Open 60.67
Previous Close 60.75
Day's Range 60.25 - 62.30
52-Week Range 55.80 - 92.35
Beta 1.17
Analysts Buy
Price Target 76.37 (+24.3%)
Earnings Date Aug 3, 2022

About BRKR

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain... [Read more...]

Industry Life Sciences Tools & Services
IPO Date Aug 4, 2000
CEO Frank Laukien
Employees 7,765
Stock Exchange NASDAQ
Ticker Symbol BRKR
Full Company Profile

Financial Performance

In 2021, Bruker's revenue was $2.42 billion, an increase of 21.66% compared to the previous year's $1.99 billion. Earnings were $277.10 million, an increase of 75.60%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is 76.37, which is an increase of 24.32% from the latest price.

Price Target
(24.32% upside)
Analyst Consensus: Buy
Stock Forecasts


Bruker Announces Quarterly Dividend

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 ...

Bruker (BRKR) Q2 Earnings Match Estimates, '22 Sales View Down

Robust performance across the BSI and BEST segments drove Bruker's (BRKR) second-quarter top line.

Bruker (BRKR) Meets Q2 Earnings Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 0% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Bruker Reports Second Quarter 2022 Financial Results

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2022. Second Quarter 2...

7 Nasdaq Stocks to Buy and Hold Forever

The Nasdaq has a reputation for being the home of aggressive hypergrowth companies — firms that can go up five- or tenfold in a year and sometimes crash just as quickly. Most investors probably wouldn't...


Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2022 financial results after market close on Wednesday, August 3, 2022....

Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective...

The round was led by Claudio Del Vecchio and joined by Bruker Corporation. NEW YORK , July 20, 2022 /PRNewswire/ -- Acuamark Diagnostics ("AcuamarkDx"), an early cancer detection company, today announce...

Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research

UTRECHT, The Netherlands--(BUSINESS WIRE)---- $BRKR #BRKR--At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHz NMR m...

Bruker (BRKR) Debuts NMR Test for Research on Long COVID Risks

Bruker's (BRKR) PhenoRisk PACS RuO will facilitate clinical research to combat the risks of Long COVID syndrome.

Bruker (BRKR) International Growth Strong Amid Competition

Bruker (BRKR) Nano Group's microelectronics and semiconductor metrology tools continue to perform well with ongoing strength in bookings and backlog.

Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID' Multi-Organ Risk Assessment

ETTLINGEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRisk PACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVI...

7 Stocks to Buy That Could Make You a Millionaire

These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments.


3 Stocks to Watch on Rising Demand for Scientific Instruments

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand, as...

Other symbols: MTDWAT

Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics

VALENCIA, Spain--(BUSINESS WIRE)---- $BRKR #BRKR--At the 18th International Conference of the Metabolomics Society, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics wit...

Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022

MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials a...

Bruker (BRKR) BSI & BEST Arms Drive Growth Amid Competition

Bruker (BRKR) Nano Group's microelectronics and semiconductor metrology tools continue to perform well with ongoing strength in bookings and backlog.

Bruker (BRKR) Debuts Module on Ultima Multiphoton Microscopes

Bruker's (BRKR) NeuraLight 3D Ultra module offers revolutionary 3D holographic photostimulation to support neuroscience and optogenetics research applications.

Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope

MADISON, Wis.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the release of the NeuraLight 3D Ultra™ module to support advanced neuroscience and optogenetics researc...

Bruker (BRKR) to Advance 4D Proteomics With Latest Launch

Bruker's (BRKR) timsTOF HT is enhanced for high-throughput, deep and unbiased plasma proteomics, and liquid biopsy biomarker research.

Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Fiel...

MINNEAPOLIS--(BUSINESS WIRE)---- $BRKR #BRKR--At the 70th ASMS Conference, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics of tissue and tumor microenvironments (TME)....

Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatogr...

MINNEAPOLIS--(BUSINESS WIRE)---- $BRKR #BRKR--At ASMS 2022, Bruker Corporation (Nasdaq: BRKR) extends the power of mass spectrometry inside and outside the laboratory to Point-of-Need (PoN) analysis wit...

Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™

MINNEAPOLIS--(BUSINESS WIRE)---- $BRKR #BRKR--At the 70th ASMS meeting, Bruker Corporation (Nasdaq: BRKR) today announced the further evolution of the revolutionary 4D Multiomics timsTOF platform with t...

Why Is Bruker (BRKR) Up 6.3% Since Last Earnings Report?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

Here's Why You Should Retain Bruker (BRKR) Stock for Now

Investors are optimistic about Bruker (BRKR) on strength across the BSI and BEST businesses.